Communiqués

07:59 Medios continues growth path in the first half of 2026 and focuses on profitability and cash conversion EQ
11/08 Medios Acquires a 74% Majority Stake in Caelo and Strengthens Its German and European Business in Active Pharmaceutical Ingredients and Excipients EQ
11/08 Medios AG – Acquisition of a Majority Stake in Caesar & Loretz GmbH (Caelo) and Entry into the German Market for Active Pharmaceutical Ingredients and Excipients EQ
04/08 Katrin Neuffer to head Investor & Public Relations at Medios AG EQ
28/07 Medios AG: Earnings guidance for the financial year 2026 reduced – revenue guidance raised at the same time EQ
28/07 Medios AG: Adjusted guidance for the financial year 2026 EQ
29/06 Medios optimizes its manufacturing network and closes its Aschaffenburg facility EQ
03/06 Medios AG: Contract of Executive Board Member Constantijn van Rietschoten extended ahead of schedule EQ
13/05 Medios : Fact Sheet May 2026 PU
12/05 Medios : Company Presentation May 2026 PU
12/05 Medios : 20260512 Medios AG Q1 2026 EN protected PU
12/05 Medios : 260511 Medios AG Press Release Q1 2026 final PU
12/05 Medios : 260512 Medios Presentation Q1 2026 final PU
12/05 Medios : Q1 2026 EN protected PU
12/05 Medios reports further revenue growth in the first quarter of 2026 and confirms guidance for the full year EQ
05/05 Medios : Unternehmenspräsentation April 2026 | Englische Version PU
29/04 Agenda item 7: Compensation System 2026 for the members of the Management Board PU
29/04 Medios : Annual Shareholders' Meeting 2026 / Agenda (Short version) PU
29/04 Agenda item 8: Compensation System 2026 for the members of the Supervisory Board PU
08/04 Medios : Company Presentation April 2026 PU
26/03 Medios : Fact Sheet March 2026 PU
26/03 Medios : 260326 Medios AG Press Release FY25 PU
26/03 Medios : DCGK Annual Declaration 2026 PU
26/03 Medios : GB 2025 EN protected PU
26/03 Medios : 260326 Medios Presentation FY25 PU
Aucun résultat pour cette recherche